Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.5 (EPT/RI) - Pfizer Inc

12th May 2014 11:34

RNS Number : 8414G
Morgan Stanley Capital Services LLC
12 May 2014
 



 

 FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley Capital Services LLC

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PFIZER INC

(c) Name of the party to the offer with which exempt principal trader is connected:

 

ASTRAZENECA PLC

(d) Date dealing undertaken:

09 MAY 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

YES

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

 Class of relevant security

 Purchases/sales

 Total number of securities

 Highest price per unit paid/received

 Lowest price per unit paid/received

 COMMON STOCK

 PURCHASES

 386,737

 29.2000 USD

 28.7800 USD

 COMMON STOCK

 SALES

 542,048

 29.2100 USD

 28.7800 USD

 

 

(b) Derivatives transactions (other than options)

 

 Class of relevant security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per unit

 COMMON STOCK

 CFD

 LONG

 2,400

 28.8913 USD

 COMMON STOCK

 CFD

 LONG

 2,800

 28.9060 USD

 COMMON STOCK

 CFD

 LONG

 700

 28.9600 USD

 COMMON STOCK

 CFD

 LONG

 240,903

 28.9645 USD

 COMMON STOCK

 CFD

 LONG

 16,700

 28.9649 USD

 COMMON STOCK

 CFD

 LONG

 42,283

 28.9896 USD

 COMMON STOCK

 CFD

 LONG

 604

 29.0100 USD

 COMMON STOCK

 CFD

 LONG

 89

 29.0100 USD

 COMMON STOCK

 CFD

 LONG

 96,500

 29.0247 USD

 COMMON STOCK

 CFD

 LONG

 5,399

 29.0376 USD

 COMMON STOCK

 CFD

 LONG

 2,324

 29.0380 USD

 COMMON STOCK

 CFD

 LONG

 3,131

 29.0385 USD

 COMMON STOCK

 CFD

 LONG

 1,018

 29.0391 USD

 COMMON STOCK

 CFD

 LONG

 22,312

 29.0445 USD

 COMMON STOCK

 CFD

 LONG

 500

 29.0700 USD

 COMMON STOCK

 CFD

 LONG

 700

 29.0771 USD

 COMMON STOCK

 CFD

 LONG

 5,254

 29.1664 USD

 COMMON STOCK

 CFD

 SHORT

 12,431

 28.7997 USD

 COMMON STOCK

 CFD

 SHORT

 5,700

 28.9005 USD

 COMMON STOCK

 CFD

 SHORT

 4,200

 28.9200 USD

 COMMON STOCK

 CFD

 SHORT

 45,200

 28.9521 USD

 COMMON STOCK

 CFD

 SHORT

 348

 28.9850 USD

 COMMON STOCK

 CFD

 SHORT

 3,825

 28.9852 USD

 COMMON STOCK

 CFD

 SHORT

 47

 28.9900 USD

 COMMON STOCK

 CFD

 SHORT

 330

 28.9900 USD

 COMMON STOCK

 CFD

 SHORT

 132

 29.0000 USD

 COMMON STOCK

 CFD

 SHORT

 20

 29.0000 USD

 COMMON STOCK

 CFD

 SHORT

 3,000

 29.0200 USD

 COMMON STOCK

 CFD

 SHORT

 26,000

 29.0221 USD

 COMMON STOCK

 CFD

 SHORT

 3,100

 29.0274 USD

 COMMON STOCK

 CFD

 SHORT

 90,400

 29.0300 USD

 COMMON STOCK

 CFD

 SHORT

 71,000

 29.0300 USD

 COMMON STOCK

 CFD

 SHORT

 57,000

 29.0378 USD

 COMMON STOCK

 CFD

 SHORT

 7,300

 29.0393 USD

 COMMON STOCK

 CFD

 SHORT

 258

 29.0425 USD

 COMMON STOCK

 CFD

 SHORT

 1,742

 29.0425 USD

 COMMON STOCK

 CFD

 SHORT

 5,521

 29.0531 USD

 COMMON STOCK

 CFD

 SHORT

 2,400

 29.0602 USD

 COMMON STOCK

 CFD

 SHORT

 10,400

 29.0880 USD

 COMMON STOCK

 CFD

 SHORT

 100

 29.0900 USD

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

 Class of relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Class of relevant security

 Product description e.g. call option

 Number of securities

 Exercise price per unit

 N/A

 N/A

 N/A

 N/A

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

Date of disclosure:

12 MAY 2014

Contact name:

Darren Wickert

Telephone number:

+44 (0)20 7425 6578

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERGGUWWAUPCGUP

Related Shares:

AstrazenecaPFZ.L
FTSE 100 Latest
Value8,680.29
Change0.00